Target intelligence / Profile preview

Sentrin-specific protease 8 (SENP8)

Target
SENP8
Molecular classification
Enzyme, Cysteine protease, Deneddylase
01

Overview

Sentrin-specific protease 8 (SENP8) is a cysteine protease enzyme that primarily catalyzes the processing and removal (deneddylation) of NEDD8—a ubiquitin-like posttranslational modifier—from substrate proteins, especially cullin-RING ligases (CRLs) and components of the NEDD8 pathway such as Ubc12[1][2][3]. SENP8 is required for proper activation of CRLs, maintenance of cell cycle progression (notably the G1/S transition), and overall protein homeostasis in cells[1]. Loss or dysfunction of SENP8 leads to accumulation of aberrantly neddylated proteins, defective proteostasis, dysregulated cell cycle progression, and can contribute to tumorigenic phenotypes[1]. The enzyme is considered a potential therapeutic target due to its central role in regulating protein turnover and cell division. SENP8 is encoded by the SENP8 gene (HGNC:22992, UniProtKB:Q96LD8) and is known by multiple names including DEN1, NEDP1, and PRSC2[2][3]. Alterations in SENP8 function have been implicated in diseases such as cancer and neurodevelopmental disorders[1][4].

Other names
DEN1NEDP1PRSC2NEDD8-specific protease 1SUMO peptidase family member, NEDD8 specificSUMO/sentrin peptidase family member, NEDD8 specific
02

Mechanism of action

Deneddylation: cleavage of NEDD8 from substrate proteins (mainly cullins, e.g., CUL1, CUL5, Ubc12); Controls substrate turnover by regulating cullin-RING E3 ligase activity

03

Biological functions

Protein deconjugation (deneddylation)Processing of NEDD8 precursorRegulation of cullin-RING ubiquitin E3 ligase activityControl of cell cycle progression (especially G1/S transition)Proteostasis regulationRegulation of neuronal development
04

Disease associations

Cancer (through cell cycle regulation and proteostasis)Potential roles in viral infection (such as Kunjin encephalitis, Kyasanur Forest Disease)Other (neuronal development and possibly neurodevelopmental disorders)
05

Safety considerations

Potential for aberrant cell cycle progression and accelerated cell growth if inhibited or knocked down, which may increase risk of tumorigenesisDisruption of proteostasis and neddylation homeostasis
06

Interacting drugs

MLN4924 (Pevonedistat)
07

Biomarkers

NEDD8 conjugation status of cullins, Ubc12, and other pathway components (e.g., increased neddylation in SENP8-deficient cells)Cell cycle distribution (especially G1/S ratio)

Beyond the preview

Go deeper on Sentrin-specific protease 8 (SENP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sentrin-specific protease 8 (SENP8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call